HEFEI,China,Sept. 21,2024-- As technology and innovation converge,a grand feast celebrating the manufacturing industry is commencing. On September 20,the 2024 World Manufacturing Convention opened its
Sep 24, 2024
HANSIZHUANG (serplulimab) is the world\'s first anti-PD-1 mAb for first-line treatment of ES-SCLC - HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody ava
Sep 24, 2024
Continuously expanding webmaster signups,especially in multiple regions,along with new highs in webmaster payouts,has ensured the smooth operation and continuous development of the project.
Sep 24, 2024
SHANGHAI,Sept. 23,2024-- At HUAWEI CONNECT 2024,Huawei launched the ICT Talent Cultivation Solution at the global education summit themed Cultivating ICT Talent to Amplify Education Intelligence. In a
Sep 24, 2024
HANOI,Vietnam,Sept. 23,2024-- On September 18,CMC Japan - the Japanese subsidiary of CMC Global celebrated the opening of its third office in Tokyo - a key milestone in its 7-year journey of bringing
Sep 24, 2024
Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales,contracting and pricing teams
Sep 24, 2024
OXFORD,England,Sept. 23,2024-- FluoRok,an Oxford-based start-up,has raised £7.7m to scale-up,manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The overs
Sep 24, 2024
BANGKOK,Sept. 23,2024-- Anytime Fitness Asia,the leading fitness franchise in Southeast Asia,proudly announces the opening of its 400th club at Exchange Tower in Bangkok,Thailand. This milestone repre
Sep 24, 2024
Hangzhou-based AI startup looks to set new standards in AI-driven educational assistance HANGZHOU,China,Sept. 23,2024-- Jingzhunxue,a Hangzhou-based education technology company,has launched "Flo
Sep 24, 2024
PARIS,Sept. 23,2024-- Yaber,a pioneer of entertainment projectors,has collaborated with the Pantone Color Institute to unveil a limited edition K3 projector in the exclusive Yaber Lunar Rock shade at
Sep 24, 2024
XPOVIO® is the first and only approved XPO1 inhibitor in Thailand. XPOVIO® has been approved for multiple indications in nine markets across the APAC region. Antengene has submitted a new dru
Sep 24, 2024
SHANGHAI,Sept. 23,2024-- On September 14,2024,BioCity presented interim clinical results on the safety and efficacy of its first-in-class antibody-drug conjugate (ADC) BC3195 targeting CDH3 (P-Cadheri
Sep 24, 2024
© TopicFashion Privacy Policy Contact us